1. Acknowledgement to Referees

   ACKNOWLEDGEMENT 18 November 2020 Pages: 1093 - 1096

2. Hormonal Contraception and Depression: Updated Evidence and Implications in Clinical Practice

   • Franca Fruzzetti
   • Tiziana Fidecicchi

   Review Article 27 September 2020 Pages: 1097 - 1106

3. Performance-Based Risk-Sharing Arrangements (PBRSA): Is it a Solution to Increase Bang for the Buck for Pharmaceutical Reimbursement Strategy for Our Nation and Around the World?

   • Andy Eunwoo Kim
   • David Hohyun Choi
   • Sean Hyungwoo Kim

   Review Article 09 October 2020 Pages: 1107 - 1113

   

4. Treatment of Major Depressive Disorder in Japanese Patients with Cancer: A Matched Cohort Study Using Employer-Based Health Insurance Claims Data

   • Tatsuo Akechi
   • Shinji Fujimoto
   • Katsuhito Murase

   Original Research Article Open access 18 October 2020 Pages: 1115 - 1125

   

5. Pharmacokinetics and Pharmacodynamics of JNJ-55920839, an Antibody Targeting Interferon α/ω, in Healthy Subjects and Subjects with Mild-to-Moderate Systemic Lupus Erythematosus

   • Zhenling Yao
   • Laura Loggia
   • Zhenhua Xu

   Original Research Article 21 October 2020 Pages: 1127 - 1136

   

6. Pembrolizumab vs the EXTREME Regimen in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Cost-Effectiveness Analysis

   • Yitian Lang
   • Deshi Dong
   • Bin Wu

   Original Research Article 23 October 2020 Pages: 1137 - 1146

   

7. Data Mining for Adverse Events of Tumor Necrosis Factor-Alpha Inhibitors in Pediatric Patients: Tree-Based Scan Statistic Analyses of Danish Nationwide Health Data

   • Viktor Wintzell
   • Henrik Svanström
   • Martin Kulldorff

   Original Research Article Open access 26 October 2020 Pages: 1147 - 1154

8. Safety, Pharmacokinetics, and Pharmacodynamics of Globalagliatin, a Glucokinase Activator, in Chinese Patients with Type 2 Diabetes Mellitus: A Randomized, Phase Ib, 28-day Ascending Dose Study

   • Shuai Zheng
   • Feng Shao
   • Tao Yang

   Original Research Article 30 October 2020 Pages: 1155 - 1166

   

9. Cost-Effectiveness of Lenvatinib Compared with Sorafenib for the First-Line Treatment of Advanced Hepatocellular Carcinoma in Australia

   • Masnoon Saiyed
   • Joshua Byrnes
   • Martin Downes

   Original Research Article 02 November 2020 Pages: 1167 - 1176

   

10. Concomitant Administration of Direct Oral Anticoagulants in Chronic Phase Chronic Myeloid Leukemia Patients Treated with Tyrosine Kinase Inhibitors

    • Alessandra Serrao
    • Emilia Scalzulli
    • Antonio Chistolini

    Short Communication 22 October 2020 Pages: 1177 - 1181